Reports for TEVA-RISEDRONATE
Brand name
TEVA-RISEDRONATE
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02298376 |
Ingredients
RISEDRONATE SODIUM |
Ingredient Strength
5 MG |
ATC Code
M05BA |
ATC Descriptor
DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVA-RISEDRONATE | 30 | Resolved | 2019-06-18 | 2019-07-16 | 86911 |
| TEVA-RISEDRONATE | P/P 30 | Resolved | 2020-03-26 | 2020-04-09 | 109592 |
| TEVA-RISEDRONATE | 30 | Resolved | 2022-06-30 | 2022-12-08 | 163948 |
| TEVA-RISEDRONATE | pp 30 | Resolved | 2025-05-30 | 2025-07-03 | 259017 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0